157 related articles for article (PubMed ID: 16624932)
1. Differential responsiveness to IFN-alpha and IFN-beta of human mature DC through modulation of IFNAR expression.
Severa M; Remoli ME; Giacomini E; Ragimbeau J; Lande R; Uzé G; Pellegrini S; Coccia EM
J Leukoc Biol; 2006 Jun; 79(6):1286-94. PubMed ID: 16624932
[TBL] [Abstract][Full Text] [Related]
2. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
Strengell M; Lehtonen A; Matikainen S; Julkunen I
J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
[TBL] [Abstract][Full Text] [Related]
3. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P
J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485
[TBL] [Abstract][Full Text] [Related]
4. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.
Buttmann M; Berberich-Siebelt F; Serfling E; Rieckmann P
J Vasc Res; 2007; 44(1):51-60. PubMed ID: 17167270
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 3 ligand-induced antiviral response in mouse osteoblastic cells.
Nakamura K; Deyama Y; Yoshimura Y; Suzuki K; Morita M
Int J Mol Med; 2007 May; 19(5):771-5. PubMed ID: 17390082
[TBL] [Abstract][Full Text] [Related]
6. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.
Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G
Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007
[TBL] [Abstract][Full Text] [Related]
7. Functional expression of human type I interferon receptors in the mouse liver.
Tochizawa S; Muraguchi M; Ohmoto Y; Oga K; Mori T
Biochem Biophys Res Commun; 2006 Jul; 346(1):61-6. PubMed ID: 16750512
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod.
Gibson SJ; Lindh JM; Riter TR; Gleason RM; Rogers LM; Fuller AE; Oesterich JL; Gorden KB; Qiu X; McKane SW; Noelle RJ; Miller RL; Kedl RM; Fitzgerald-Bocarsly P; Tomai MA; Vasilakos JP
Cell Immunol; 2002; 218(1-2):74-86. PubMed ID: 12470615
[TBL] [Abstract][Full Text] [Related]
9. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.
Abramovich C; Shulman LM; Ratovitski E; Harroch S; Tovey M; Eid P; Revel M
EMBO J; 1994 Dec; 13(24):5871-7. PubMed ID: 7813427
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β.
de Paus RA; van Wengen A; Schmidt I; Visser M; Verdegaal EM; van Dissel JT; van de Vosse E
Cytokine; 2013 Feb; 61(2):645-55. PubMed ID: 23299081
[TBL] [Abstract][Full Text] [Related]
11. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors.
Takauji R; Iho S; Takatsuka H; Yamamoto S; Takahashi T; Kitagawa H; Iwasaki H; Iida R; Yokochi T; Matsuki T
J Leukoc Biol; 2002 Nov; 72(5):1011-9. PubMed ID: 12429724
[TBL] [Abstract][Full Text] [Related]
12. Interferon (IFN)-induced protein 35 (IFI35) negatively regulates IFN-β-phosphorylated STAT1-RIG-I-CXCL10/CCL5 axis in U373MG astrocytoma cells treated with polyinosinic-polycytidylic acid.
Shirai K; Shimada T; Yoshida H; Hayakari R; Matsumiya T; Tanji K; Murakami M; Tanaka H; Imaizumi T
Brain Res; 2017 Mar; 1658():60-67. PubMed ID: 28109979
[TBL] [Abstract][Full Text] [Related]
13. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
14. Loss of type I IFN receptors and impaired IFN responsiveness during terminal maturation of monocyte-derived human dendritic cells.
Gauzzi MC; Canini I; Eid P; Belardelli F; Gessani S
J Immunol; 2002 Sep; 169(6):3038-45. PubMed ID: 12218119
[TBL] [Abstract][Full Text] [Related]
15. IFN-beta modulates the response to TLR stimulation in human DC: involvement of IFN regulatory factor-1 (IRF-1) in IL-27 gene expression.
Remoli ME; Gafa V; Giacomini E; Severa M; Lande R; Coccia EM
Eur J Immunol; 2007 Dec; 37(12):3499-508. PubMed ID: 17985330
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression.
Coelho LF; Magno de Freitas Almeida G; Mennechet FJ; Blangy A; Uzé G
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11917-22. PubMed ID: 16081539
[TBL] [Abstract][Full Text] [Related]
17. Requirement for STAT1 in LPS-induced gene expression in macrophages.
Ohmori Y; Hamilton TA
J Leukoc Biol; 2001 Apr; 69(4):598-604. PubMed ID: 11310846
[TBL] [Abstract][Full Text] [Related]
18. IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro.
Vitale G; de Herder WW; van Koetsveld PM; Waaijers M; Schoordijk W; Croze E; Colao A; Lamberts SW; Hofland LJ
Cancer Res; 2006 Jan; 66(1):554-62. PubMed ID: 16397272
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms for regulation of cellular responsiveness to human IFN-beta1a.
Dupont SA; Goelz S; Goyal J; Green M
J Interferon Cytokine Res; 2002 Apr; 22(4):491-501. PubMed ID: 12034032
[TBL] [Abstract][Full Text] [Related]
20. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
